Top articles to read on World Vitiligo Day
Since 2011, June 25 has been recognized as World Vitiligo Day to raise awareness of this rare and often misunderstood condition — one that affects about 1% of the world’s population, according to the Cleveland Clinic.
In recognition of this event, Healio Dermatology has compiled a list of recent articles focused on important developments in vitiligo research.
Researchers encourage use of topical calcineurin inhibitors for vitiligo
Topical calcineurin inhibitors may produce a favorable response in patients with vitiligo, with monotherapy appearing to be effective in children and in those with lesions on the face and neck. Read more.
Results ‘promising’ in phase 2 study of ruxolitinib cream for patients with vitiligo
Around half of patients with vitiligo treated with ruxolitinib cream achieved a 50% improvement in facial vitiligo area severity index scores at week 24, meeting the primary endpoint in a phase 2 study, David Rosmarin, MD, primary investigator of the study, said in an interview with Healio Dermatology. Read more.
Vitiligo with ocular involvement associated with dry eye
Periocular involvement in vitiligo may make patients more susceptible to dry eye than those with vitiligo without ocular involvement, according to a study. Read more.
Smartphone may be readily available alternative to Wood’s lamp
In vitiligo, visualization and accentuation of lesions using blue light emitted from a smartphone was comparable to a Wood’s lamp and may be useful in resource-poor settings where a lamp is not available. Read more.